GNI Group (2160) Price & Analysis

Compare

3 Followers

2160 Stock Chart & Stats

¥2290.00

¥50.00(1.64%)

At close: Jan 08 4:00 PM EST

¥2290.00

¥50.00(1.64%)

Day’s Range― - ―

52-Week Range¥1,469.00 - ¥4,410.00

Previous CloseN/A

Volume492.20K

Average Volume (3M)969.16K

Market Cap

¥173.46B

Enterprise Value¥184.84B

Total Cash (Recent Filing)¥21.10B

Total Debt (Recent Filing)¥6.36B

Price to Earnings (P/E)―

Beta1.31

Next Earnings

May 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-74.44

Shares Outstanding55,685,127

10 Day Avg. Volume1,104,200

30 Day Avg. Volume969,156

Financial Highlights & Ratios

PEG Ratio0.06

Price to Book (P/B)2.52

Price to Sales (P/S)4.71

P/FCF Ratio-46.15

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)32.28

Revenue Forecast (FY)¥41.97B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetA low debt-to-equity (~0.13 in 2025) and materially grown equity create durable financial flexibility. This conservative capital structure gives the company a buffer against operating volatility, preserves borrowing capacity for R&D or M&A, and reduces insolvency risk over the medium term.

Long-term Revenue Growth TrendSustained revenue expansion from 2020–2025 and a 2025 rebound indicate underlying demand resilience and market traction. This multi-year growth trend supports strategic investment decisions and suggests the business model retains structural customers or products that can drive recovery in margins and cash generation.

High Gross MarginsPersistently high gross margins imply strong product differentiation or pricing power at the core of the business. If management controls operating costs, these structural gross margins can translate into durable operating profitability and free cash flow once operating expense volatility is addressed.

Bears Say

Sustained Cash BurnConsecutive years of negative operating and free cash flow indicate the business is not self-funding current operations. Persistent cash burn elevates refinancing and dilution risk, constrains strategic investments, and forces reliance on external financing that can alter capital structure or shareholder returns over the medium term.

Sharp Profitability DeteriorationA swing from prior profitability to operating and net losses in 2025 reflects a structural hit to earnings quality. Sustained losses erode retained earnings and can limit reinvestment capacity, making it harder to fund growth or absorb shocks without altering strategy or securing external capital.

Volatile Growth And Margin PressureRevenue and margin volatility, including a 2024 decline and a collapse in operating/net margins, reduce predictability of cash flows and complicate planning. Structural or recurring cost pressures would impede margin recovery and raise execution risk for restoring sustainable profitability.

GNI Group News

GNI Group Revises Parent-Only Results After Tax and Valuation Adjustments

GNI Group ( ($JP:2160) ) has provided an update. GNI Group Ltd. has announced corrections to previously disclosed...

3d ago

GNI Group Revamps Board Slate With New Independent Director Ahead of AGM

GNI Group ( ($JP:2160) ) has shared an update. GNI Group Ltd. has proposed a slate of director...

3d ago

GNI Group Revises FY2025 Results After Overstated CFC Tax Expense

An update from GNI Group ( ($JP:2160) ) is now available. GNI Group has announced a partial correction...

3d ago

GNI Group’s Gyre Therapeutics to acquire Cullgen in $300 million all-stock deal

An update from GNI Group ( ($JP:2160) ) is now available. GNI Group’s Nasdaq-listed subsidiary Gyre Therapeutics has...

4d ago

GNI Group Swings to Non-Consolidated Loss on Absence of One-Off Gain and Forward Transaction Hit

GNI Group ( ($JP:2160) ) has issued an update. GNI Group Ltd., a biopharmaceutical company listed on the...

22d ago

GNI Group Swings to Loss in FY2025 Despite Higher Revenue and Stronger Equity Base

GNI Group ( ($JP:2160) ) has issued an update. GNI Group reported FY2025 consolidated revenue of ¥26.84 billion,...

22d ago

GNI Group Delays 2026 Earnings Forecast Amid Regulatory and Pipeline Uncertainty

GNI Group ( ($JP:2160) ) has issued an update. GNI Group has postponed the disclosure of its full-year...

22d ago

GNI Group Explains Acquisition Plans, Earnings Revision and F351 Disclosure Strategy

GNI Group ( ($JP:2160) ) has issued an update. GNI Group has addressed a series of investor questions...

23d ago

3G6 Earnings this Week: How Will it Perform?

GNI Group (3G6) is scheduled to report 4th quarter earnings on 02/13/2026. Regarding Q4 estimates, Wall Street analysts...

24d ago

GNI Group Slashes 2025 Profit Outlook as Cullgen Listing Is Delayed and Impairment Losses Loom

GNI Group ( ($JP:2160) ) has issued an update. GNI Group has sharply revised its full-year 2025 consolidated...

1M ago

2160 FAQ

What was GNI Group Ltd.’s price range in the past 12 months?

GNI Group Ltd. lowest stock price was ¥1469.00 and its highest was ¥4410.00 in the past 12 months.

What is GNI Group Ltd.’s market cap?

GNI Group Ltd.’s market cap is ¥173.46B.

When is GNI Group Ltd.’s upcoming earnings report date?

GNI Group Ltd.’s upcoming earnings report date is May 18, 2026 which is in 72 days.

How were GNI Group Ltd.’s earnings last quarter?

GNI Group Ltd. released its earnings results on Feb 13, 2026. The company reported -¥74.44 earnings per share for the quarter, missing the consensus estimate of ¥224.642 by -¥299.082.

Is GNI Group Ltd. overvalued?

According to Wall Street analysts GNI Group Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does GNI Group Ltd. pay dividends?

GNI Group Ltd. does not currently pay dividends.

What is GNI Group Ltd.’s EPS estimate?

GNI Group Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does GNI Group Ltd. have?

GNI Group Ltd. has 55,685,127 shares outstanding.

What happened to GNI Group Ltd.’s price movement after its last earnings report?

GNI Group Ltd. reported an EPS of -¥74.44 in its last earnings report, missing expectations of ¥224.642. Following the earnings report the stock price went down -3.49%.

Which hedge fund is a major shareholder of GNI Group Ltd.?

Currently, no hedge funds are holding shares in JP:2160

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

GNI Group Ltd.

GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial phase II and pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase II clinical trial for the treatment of liver fibrosis; and F573 that is in pre-clinical phase for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.